In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio. FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling The peptide problem: Hype is outrunning the evidence Is Your Peptide Store Website FDA Aligned? onPoint Studio Web Design and Development Services 2026 predictions: historic FDA shift, plausible mechanisms, bespoke tx, RFK Jr., biotechs, state AGs, peptides, embryos The Niche